Super Bowl LIX is already proving to offer serious star power, with ad spots led by Chris Pratt, Eugene Levy, Michelle Rodriguez and even a When Harry Met Sally reunion with Meg Ryan and Billy Crystal ...

Health-care companies fell, but not by as much as the broad market, amid a generally strong round of earnings from drugmakers. AbbVie shares rose after the pharmaceutical company reported ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

The potential step by the social-media giant follows a similar move by Elon Musk, who moved to reincorporate his companies in Texas and Nevada. Intuit can only use money from the facility for its ...

Aggressive treatment before ocular surgery helps avoid postoperative issues with visual quality in patients with dry eye ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and core operating income rising 29% in constant currency. For the full year, the company achieved a ...

Novartis chief executive says large pharma deals usually don't pay off. But the company remains interested in bolt-on ...

One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...

Ionis Pharmaceuticals (IONS) stock slips as Novartis (NVS) delays Phase 3 trial data for its cardiac therapy pelacarsen. Read ...

The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

Swiss drug-major Novartis AG reported Friday weak net earnings in its fourth quarter on the absence of prior year's significant gain ...